Sagimet Biosciences Inc.

SGMT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$32,496$42,327$64,717$75,840
Short-Term Investments$84,197$83,080$79,852$75,410
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,540$1,789$1,503$1,524
Total Curr. Assets$119,233$127,196$146,072$152,774
Property Plant & Equip (Net)$115$152$38$77
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$8,806$10,059$0$7,408
Tax Assets$0$0$0$0
Other NC Assets$247$0$62$0
Total NC Assets$9,168$10,211$100$7,485
Other Assets$0$0$0$0
Total Assets$128,401$137,407$146,172$160,259
Liabilities
Payables$4,243$1,921$3,223$1,425
Short-Term Debt$115$152$39$78
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,788$5,174$3,918$2,951
Total Curr. Liab.$9,146$7,247$7,180$4,454
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$152$39$78
Total Liabilities$9,146$7,247$7,180$4,454
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$336,781-$323,873-$313,487-$295,311
AOCI$117$76$121$230
Other Equity$455,916$453,954$452,355$450,883
Total Equity$119,255$130,160$138,992$155,805
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$128,401$137,407$146,172$160,259
Net Debt-$32,381-$42,175-$64,678-$75,762